<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02231957</url>
  </required_header>
  <id_info>
    <org_study_id>AAAM3756</org_study_id>
    <nct_id>NCT02231957</nct_id>
  </id_info>
  <brief_title>Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions</brief_title>
  <official_title>Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are a growing number of adolescents with chronic medical conditions in the United
      States. The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination
      and annual influenza vaccination of all adolescents. Pneumococcal polysaccharide vaccination
      is also recommended for certain high-risk patients. Limited studies suggest that vaccination
      coverage of this population remains sub-optimal. Text message vaccine reminder/recall has
      been shown to be effective in increasing uptake of select pediatric and adolescents vaccines,
      but has yet to be examined among patients with chronic medical conditions who may also face
      unique barriers to vaccination. This intervention aims to implement and evaluate the use of
      text message vaccine reminders among urban low-income minority adolescents with chronic
      medical conditions. This investigator-initiated study is supported in part by a grant from
      the Pfizer Medical Education Group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2014</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)</measure>
    <time_frame>12 weeks after intervention start</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)</measure>
    <time_frame>4 weeks after intervention start</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)</measure>
    <time_frame>24 weeks after intervention start</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination</measure>
    <time_frame>4 weeks after intervention start</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination</measure>
    <time_frame>12 weeks after intervention start</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination</measure>
    <time_frame>24 weeks after intervention start</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">416</enrollment>
  <condition>Vaccination</condition>
  <arm_group>
    <arm_group_label>educational text message reminders</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>receipt of education-embedded text message vaccine reminders</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional text message reminders</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>receipt of conventional text message vaccine reminders</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>educational text message reminders</intervention_name>
    <arm_group_label>educational text message reminders</arm_group_label>
    <other_name>educational text message vaccine reminders</other_name>
    <other_name>education-embedded text message vaccine reminders</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>conventional text message reminders</intervention_name>
    <arm_group_label>conventional text message reminders</arm_group_label>
    <other_name>conventional text message vaccine reminders</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Parent with

          1. adolescent aged 11-17 years;

          2. adolescent with â‰¥1 chronic medical condition;

          3. adolescent with clinic visit in last 12 months;

          4. cell phone number listed in hospital registration system

        Exclusion Criteria:

        Parent who:

          1. does not speak English or Spanish;

          2. is unwilling to receive text message vaccine reminders;

          3. anticipates moving from area in coming 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annika M Hofstetter, MD, PhD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NewYork-Presbyterian Hospital/Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2014</study_first_submitted>
  <study_first_submitted_qc>September 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2014</study_first_posted>
  <last_update_submitted>January 27, 2017</last_update_submitted>
  <last_update_submitted_qc>January 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Annika Hofstetter</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

